Tissue engineering for cutaneous wounds

Journal of Investigative Dermatology

Volumn 127, Issue 5, 2007, Pages 1018-1029

  Clark, Richard A F ^a,b   Ghosh, Kaustabh ^a   Tonnesen, Marcia G ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER;

BIOMIMETICS; GENETIC ENGINEERING; IMMUNOSURVEILLANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN INJURY; SKIN TRANSPLANTATION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TISSUE REGENERATION; WOUND CARE; WOUND CLOSURE;

EID: 34247191989     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700715     Document Type: Article

References (112)

1. Alisky JM (2004) Xenografts are an achievable breakthrough. Med Hypotheses 63:92-7
2. American Burn Association (2005a) Burn incidence and treatment in the US: 2000 fact sheet. http://www.ameriburn.org/pub/BurnIncidenceFactSheet.htm.
3. Ashcroft GS, Mills SJ, Lei K, Gibbons L, Jeong MJ, Taniguchi M et al. (2003) Estrogen modulates cutaneous wound healing by down-regulating macrophage migration inhibitory factor. J Clin Invest 111:1309-18
4. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P (2003) Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 196:245-50
5. Balasubramani M, Kumar TR, Babu M (2001) Skin substitutes: a review. Burns 27:534-44
6. Basu A, Castle VP, Bouziane M, Bhalla K, Haldar S (2006) Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res 66:4309-18
7. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T (1981) Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211:1052-4
8. Bell E, Ivarsson B, Merrill C (1979) Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci (USA) 76:1274-8
9. Bouchle A (2002) Tissue engineering firms go under. Nat Biotechnol 20:1178-9
10. Bourguignon LY, Ramez M, Gilad E, Singleton PA, Man MQ, Crumrine DA et al. (2006) Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis. J Invest Dermatol 126:1356-65
11. Burke JF, Yannas IV, Quinby WC Jr, Bondoc CC, Jung WK (1981) Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194:413-28
12. Cai S, Liu Y, Zheng Shu X, Prestwich GD (2005) Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 26:6054-67
13. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, William (1998) Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19:2101-27
14. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J et al. (2003) Mesenchymal stem cells home to injured tissues when coinfused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 5:1028-38
15. Chen WY, Abatangelo G (1999) Functions of hyaluronan in wound repair. Wound Repair Regen 7:79-89
16. Chiquet M, Renedo AS, Huber F, Fluck M (2003) How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biol 22:73-80
17. Clark RAF, An J-Q, Greiling D, Khan AJ, Schwarzbauer J (2003) Fibroblast migration on fibronectin requires 3 distinct functional domains. J Invest Dermatol 121:695-705
18. Crowe MJ, Doetschman T, Greenhalgh DG (2000) Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 115:3-11
19. Cuono C, Langdon R, McGuire J (1986) Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1:1123-4
20. De Luca M, Albanese E, Cancedda R, Viacava A, Faggioni A, Zambruno G et al. (1992) Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. Arch Dermatol 128:633-8
21. Discher DE, Janmey P, Wang YL (2005) Tissue cells feel and respond to the stiffness of their substrate. Science 310:1139-43
22. Dvorak HF (1986) Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-9
23. Eaglstein WH, Alvarez OM, Auletta M, Leffel D, Rogers GS, Zitelli JA et al. (1999) Acute excisional wounds treated with a tissue-engineered skin (Apligraf). Dermatol Surg 25:195-201
24. Eaglstein WH, Iriondo M, Laszlo K (1995) A composite skin substitute (graftskin) for surgical wounds: a clinical experience. Dermatol Surg 21:839-43
25. Ehrenreich M, Ruszczak Z (2006) Update on tissue-engineered biological dressings. Tissue Eng 12:1-18
26. Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126:677-89
27. Enoch S, Shaaban H, Dunn KW (2005) Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material. J Med Ethics 31:2-6
28. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M et al. (1998) Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group [see comments]. Arch Dermatol 134:293-300
29. Gallico GG III, O'Connor NE, Compton CC, Kehinde O, Green H (1984) Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311:448-51
30. Geiger B, Bershadsky A, Pankov R, Yamada KM (2001) Transmembrane crosstalk between the extracellular matrix-cytoskeleton cross-talk. Nat Rev Mol Cell Biol 2:793-805
31. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta et al. (1996) Use of dermagraft: a cultured human dermis to treat diabetic foot ulcers. Diabetes Care 19:350-4
32. Ghosh K, Clark RAF (2007) Wound repair: basic biology to tissue engineering. In Principles of tissue engineering. (R. Lanza, R. Langer, J.P. Vacanti, eds) Elsevier/Academic Press in press.
33. Ghosh K, Pan Z, Guan E, Ge S, Liu Y, Nakamura T et al. (2006a) Cell adaptation to a physiologically relevant ECM mimic with different viscoelastic properties. Biomaterials 28:671-9
34. Ghosh K, Ren XD, Shu XZ, Prestwich GD, Clark RA (2006b) Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng 12:601-13
35. Ghosh K, Shu XZ, Mou R, Lombardi J, Prestwich GD, Rafailovich MH et al. (2005) Rheological characterization of in situ cross-linkable hyaluronan hydrogels. Biomacromolecules 6:2857-65
36. Gobin AS, West JL (2002) Cell migration through defined, synthetic ECM analogs. FASEB J 16:751-3
37. Gokoo C, Burhop K (1993) A comparative study of wound dressings on full-thickness wounds in micropigs. Decubitus 6:42-3 , 46, 48 passim.
38. Grant I, Warwick K, Marshall J, Green C, Martin R (2002) The co-application of sprayed cultured autologous keratinocytes and autologous fibrin sealant in a porcine wound model. Br J Plast Surg 55:219-27
39. Green H, Kehinde O, Thomas J (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 76:5665-8
40. Greiling D, Clark RAF (1997) Fibronectin provides a conduit for fibroblast transmigration from a collagen gel into a fibrin gel. J Cell Sci 110(Part 7):861-70
41. Grinnell F, Ho CH, Wysocki AJ (1992) Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410-6
42. Grinnell F, Lamke CR (1984) Reorganization of hydrated collagen lattices by human skin fibroblasts. J Cell Sci 66:51-63
43. Grinnell F, Zhu M (1996) Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 106:335-41
44. Gui Y, Murphy LJ (2001) Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. J Clin Endocrinol Metab 86:2104-10
45. Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J et al. (1988) Artificial dermis for major burns: a multicenter randomized clinical trial. Ann Surg 208:313-20
46. Herrick SE, Ireland G, Simon D, McCollum C, Ferguson MWJ (1996) Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. J Invest Dermatol 106:187-93
47. Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MWJ (1992) Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 141:1085-95
48. Hersel U, Dahmen C, Kessler H (2003) RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24:4385-415
49. Hinz B (2006) Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol 85:175-81
50. Hoshi H, Nakagawa H, Nishiguchi S, Iwata K, Niikura K, Monde K et al. (2004) An engineered hyaluronan synthase: characterization for recombinant human hyaluronan synthase 2 Escherichia coli. J Biol Chem 279:2341-9
51. Huang S, Ingber DE (1999) The structural and mechanical complexity of cell-growth control. Nat Cell Biol 1:E131-8
52. Ingber DE (2003) Tensegrity II. How structural networks influence cellular information processing networks. J Cell Sci 116:1397-408
53. Ji Y, Ghosh K, Shu XZ, Li B, Sokolov JC, Prestwich GD et al. (2006) Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds. Biomaterials 27:3782-92
54. Kirker KR, Luo Y, Nielson JH, Shelby J, Prestwich GD (2002) Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 23:3661-71
55. Klagsbrun M (1990) The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix. Curr Opin Cell Biol 2:857-63
56. Kubo M, Van de Water L, Plantefaber LC, Mosesson MW, Simon M, Tonnesen MG et al. (2001) Fibrinogen and fibrin are antiadhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J Invest Dermatol 117:1369-81
57. Leigh IM, Purkis PE, Navasaria HA, Phillips TJ (1987) Treatment of chronic venous ulcers with sheets of cultured allogeneic keratinocytes. Br J Dermatol 117:591-7
58. Lo CM, Wang HB, Dembo M, Wang YL (2000) Cell movement is guided by the rigidity of the substrate. Biophys J 79:144-52
59. Longaker MT, Chiu E, Adzick NS, Stern M, Harrison M, Stern R (1991) Studies in fetal wound healing V. A prolonged presence of hyaluraonic acid characterizes fetal wound fluid. Ann Surg 213:290-6
60. Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23:47-55
61. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB et al. (2003) Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 100:5413-8
62. Lysek DA, Schorn C, Nivon LG, Esteve-Moya V, Christen B, Calzolai L et al. (2005) Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci USA 102:640-5
63. Madden MR, Finkelstein JL, Staiano-Coico L, Goodwin CW, Shires GT, Nolan EE et al. (1986) Grafting of cultured allogeneic epidermis on second and third degree burn wounds on 26 patients. J Trauma 26:955-62
64. Markets for advanced wound care technologies. (2003) http://www.the- infoshop.com/study/bc25780_wound_care.html
65. Marston WA, Hanft J, Norwood P, Pollak R (2003) The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26:1701-5
66. McClain SA, Simon M, Jones E, Nandi A, Gailit J, Newman D et al. (1996) Mesenchymal cell activation is the rate limiting step of granulation tissue induction. Am J Pathol 149:1257-70
67. Medical Data International, Inc. (1993) Wound Care in the US: emerging Trends, Management and New Product Development
68. Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3:1894-904
69. Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D (2005) Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41:837-43
70. Munster AM (1996) Cultured skin for massive burns. A prospesctive, controlled trial. Ann Surg 224:372-7
71. Mustoe T (2004) Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 187:65S-70S
72. Nelson CM, Bissell M (2006) Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22:287-309
73. Nunery WR (2001) Risk of prion transmission with the use of xenografts and allografts in surgery. Ophthal Plast Reconstr Surg 17:389-94
74. O'Conner NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H (1981) Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1:75-8
75. Odessey R (1992) Addendum: multicenter experience with cultured epidermal autograft for treatment of burns. J Burn Care Rehab 13:174-80
76. Olin JW, Beusterien KM, Childs MB, Seavey C, McHugh L, Griffiths RI (1999) Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study. Vasc Med 4:1-7
77. Peters T, Sindrilaru A, Hinz B, Hinrichs R, Menke A, Al-Azzeh EA et al. (2005) Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J 24:3400-10
78. Pfaff M (1997) Recognition sites of RGD-dependent integrins. In Integrin-ligand interaction. (J.A. Eble eds.), pp Germany: Springer-Verlag, Heidelberg, 101-21
79. Phillips T (1998) New skin for old: developments in biological skin substitutes. Arch Dermatol 134:344-9
80. Pierschbacher MD, Polarek JW, Craig WS, Tschopp JF, Sipes NJ, Harper JR (1994) Manipulation of cellular interactions with biomaterials toward a therapeutic outcome: a perspective. J Cell Biochem 56:150-4
81. Pierschbacher MD, Ruoslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-3
82. Prestwich GD, Marecak DM, Marecek JF, Vercruysse KP, Ziebell MR (1998) Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release 53:93-103
83. Purdue GF (1997) Dermagraft-TC pivotal safety and efficacy study. J Burn Care Rehabil 18:S13-4
84. Purna SK, Babu M (2000) Collagen based dressings - a review. Burns 26:54-62
85. Redd MJ, Cooper L, Wood W, Stramer B, Martin P (2004) Wound healing and inflammation: embryos reveal the way to perfect repair. Philos Trans Roy Soc London B 359:777-84
86. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-44
87. Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029-34
88. Riveline D, Zamir E, Balaban NQ, Schwarz US, Ishizaki T, Narumiya S et al. (2001) Focal contacts as mechanosensors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol 153:1175-86
89. Robson MC, Krizek TJ, Koss N, Samburg JL (1973) Amniotic membranes as a temporary wound dressing. Surg Gynecol Obstet 136:904-6
90. Rosso F, Marino G, Giordano A, Barbarisi M, Parmeggiani D, Barbarisi A (2005) Smart materials as scaffolds for tissue engineering. J Cell Physiol 203:465-70
91. Rue LW III, Cioffi WG, McManus WF, Pruitt Jr BA (1993) Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. J Trauma 34:662-7 ; discussion 667-8.
92. Ruszczak Z (2003) Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55:1595-611
93. Sabolinski ML, Alverez O, Auletta M, Mulder G, Parenteau NL (1996) Cultured skin as a "smart material" for healing wounds: experience in venous ulcers. Biomaterials 17:311-20
94. Sahni A, Francis CW (2000) Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96:3772-8
95. Sahni A, Sahni SK, Simpson-Haidaris PJ, Francis CW (2004) Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells. J Thromb Haemost 2:1629-36
96. Sakai S, Yasuda R, Sayo T, Ishikawa O, Inoue S (2000) Hyaluronan exists in the normal stratum corneum. J Invest Dermatol 114:1184-7
97. Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C et al. (2005) Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 118:2363-70
98. Shu X, Liu Y, Luo Y, Roberts M, Prestwich G (2002) Disulfide crosslinked hyaluronan hydrogels. Biomacromolecules 3:1304-11
99. Shu XZ, Ghosh K, Liu Y, Palumbo FS, Luo Y, Clark RA et al. (2004) Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res 68A:365-75
100. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738-46
101. Still J, Glat P, Silverstein P, Griswold J, Mozingo D (2003) The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 29:837-41
102. Supp DM, Boyce ST (2005) Engineered skin substitutes: practices and potentials. Clin Dermatol 23:403-12
103. Teepe RGC, Koebrugge EJ, Ponec M, Vermeer BJ (1990) Fresh versus cryopreserved cultured allografts for the treatment of chronic skin ulcers. Br J Dermatol 122:81-9
104. Thivolet J, Faure M, Demidem A, Mauduit G (1986) Long term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation 42:274-80
105. Toole BP, Zoltan-Jones A, Misra S, Ghatak S (2005) Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions. Cells Tissues Organs 179:66-72
106. US Department of Health and Human Services (2005b) National Diabetes Fact Sheet. C.f.D.C.a Prevention. Atlanta, GA: US Department of Health and Human Services
107. Vogel V, Sheetz M (2006) Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol 7:265-75
108. Welch MP, Odland GF, Clark RAF (1990) Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110:133-45
109. Wells GA, Hawkins SA, Austin AR, Ryder SJ, Done SH, Green RB et al. (2003) Studies of the transmissibility of the agent of bovine spongiform encephalopathy to pigs. J Gen Virol 84:1021-31
110. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K et al. (2002) Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 91:25-31
111. Williamson JS, Snelling CF, Clugston P, Macdonald IB, Germann E (1995) Cultured epithelial autograft: five years of clinical experience with twenty-eight patients. J Trauma 39:309-19
112. Wisniewski HG, Vilcek J (1997) TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev 8:143-56